SOPHiA GENETICS today announced the close of a $30-million Series D funding round. The round was led by London-based Balderton Capital, joined by 360º Capital Partners, alongside existing investors British tech star Mike Lynch's Invoke Capital and Alychlo, Belgian pharmaceutical entrepreneur Marc Coucke’s investment firm. The